• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯胺酮的作用机制。

Mechanism of action of ketamine.

出版信息

CNS Spectr. 2013 Aug;18(4):171-4. doi: 10.1017/S109285291300045X.

DOI:10.1017/S109285291300045X
PMID:23866089
Abstract

Ketamine induces rapid-onset and short-duration improvement in depressive and suicidal symptoms in both treatment-resistant unipolar depression and bipolar depression, and also reduces chronic pain after short intravenous infusions. In order to develop long-acting oral agents with the same clinical effects, the pharmacologic mechanism of action must be understood, and the leading hypotheses are discussed here.

摘要

氯胺酮可迅速缓解治疗抵抗性单相和双相抑郁患者的抑郁和自杀症状,并在短时间静脉输注后减轻慢性疼痛。为了开发具有相同临床效果的长效口服制剂,必须了解其药理作用机制,本文讨论了主要假说。

相似文献

1
Mechanism of action of ketamine.氯胺酮的作用机制。
CNS Spectr. 2013 Aug;18(4):171-4. doi: 10.1017/S109285291300045X.
2
Ketamine as an alternative treatment for treatment-resistant depression.氯胺酮作为难治性抑郁症的一种替代治疗方法。
Perspect Psychiatr Care. 2013 Jan;49(1):2-4. doi: 10.1111/ppc.12006. Epub 2012 Dec 30.
3
N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.N-甲基-D-天冬氨酸谷氨酸受体拮抗剂与速效抗抑郁药的前景。
Arch Gen Psychiatry. 2010 Nov;67(11):1110-1. doi: 10.1001/archgenpsychiatry.2010.138.
4
Ketamine for Treatment-Resistant Depression: a New Advocate.氯胺酮用于治疗抵抗性抑郁症:一位新的支持者。
Rev Invest Clin. 2018;70(2):65-7. doi: 10.24875/RIC.18002501.
5
A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.氯胺酮在情感障碍中的应用综述:临床疗效的现有证据、使用限制以及作用机制的临床前证据。
J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10.
6
Ketamine for Major Depressive Disorder.氯胺酮治疗重度抑郁症。
Curr Top Behav Neurosci. 2024;66:131-147. doi: 10.1007/7854_2023_453.
7
[Ketamine for treatment of acute depression].[氯胺酮用于治疗急性抑郁症]
Ugeskr Laeger. 2013 Sep 9;175(37):2090-3.
8
NMDA antagonist treatment of depression.NMDA拮抗剂治疗抑郁症。
Curr Opin Neurobiol. 2016 Feb;36:112-7. doi: 10.1016/j.conb.2015.11.001. Epub 2015 Dec 11.
9
Intravenous ketamine for treatment-resistant major depressive disorder.静脉注射氯胺酮治疗难治性重度抑郁症。
Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20.
10
[Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].N-甲基-D-天冬氨酸(NMDA)谷氨酸受体拮抗剂氯胺酮在难治性抑郁症治疗中的抗抑郁作用
Psychiatr Pol. 2012 Mar-Apr;46(2):283-94.

引用本文的文献

1
Ketamine-Induced Uropathy in a High-Prevalence Region: Knowledge, Diagnostic Practices, and Treatment Patterns Among Primary and Secondary Care Providers.高流行地区的氯胺酮诱发的尿路病:初级和二级医疗服务提供者的认知、诊断实践及治疗模式
Cureus. 2025 Jun 19;17(6):e86373. doi: 10.7759/cureus.86373. eCollection 2025 Jun.
2
Ketamine effects on resting state functional brain connectivity in major depressive disorder patients: a hypothesis-driven analysis based on a network model of depression.氯胺酮对重度抑郁症患者静息态脑功能连接的影响:基于抑郁症网络模型的假设驱动分析。
Front Neurosci. 2025 Feb 3;19:1531375. doi: 10.3389/fnins.2025.1531375. eCollection 2025.
3
Neutrophils and Anesthetic Drugs: Implications in Onco-Anesthesia.
中性粒细胞与麻醉药物:肿瘤麻醉学相关影响
Int J Mol Sci. 2024 Apr 4;25(7):4033. doi: 10.3390/ijms25074033.
4
Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors.在果蝇中微剂量使用氯胺酮不会阻断5-羟色胺再摄取,但会引起由谷氨酸和5-羟色胺受体介导的复杂行为变化。
J Neurochem. 2024 Jun;168(6):1097-1112. doi: 10.1111/jnc.16070. Epub 2024 Feb 7.
5
Microdosing ketamine in does not inhibit SERT like SSRIs, but causes behavioral changes mediated by glutamate and serotonin receptors.小剂量氯胺酮不会像选择性5-羟色胺再摄取抑制剂(SSRIs)那样抑制5-羟色胺转运蛋白(SERT),而是会引起由谷氨酸和血清素受体介导的行为变化。
bioRxiv. 2023 Nov 8:2023.11.07.566121. doi: 10.1101/2023.11.07.566121.
6
Age, Dose, and Locomotion: Decoding Vulnerability to Ketamine in C57BL/6J and BALB/c Mice.年龄、剂量与运动能力:解析C57BL/6J和BALB/c小鼠对氯胺酮的易感性
Biomedicines. 2023 Jun 25;11(7):1821. doi: 10.3390/biomedicines11071821.
7
Recent Developments in Pharmacotherapy of Depression: Bench to Bedside.抑郁症药物治疗的最新进展:从实验台到病床边
J Pers Med. 2023 Apr 29;13(5):773. doi: 10.3390/jpm13050773.
8
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.针对西格玛受体治疗神经退行性和神经发育障碍。
CNS Drugs. 2023 May;37(5):399-440. doi: 10.1007/s40263-023-01007-6. Epub 2023 May 11.
9
A unified model of ketamine's dissociative and psychedelic properties.氯胺酮致分离性和致幻性的统一模型。
J Psychopharmacol. 2023 Jan;37(1):14-32. doi: 10.1177/02698811221140011. Epub 2022 Dec 17.
10
The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.缺失的环节?小胶质细胞在麻醉剂、氯胺酮和迷幻药治疗作用中起重要作用的实例
Neurochem Res. 2023 Apr;48(4):1129-1166. doi: 10.1007/s11064-022-03772-0. Epub 2022 Nov 3.